The Maudsley Hospital is part of the South London and Maudsley NHS Foundation Trust. The Trust constitutes a large local mental health trust and a teaching hospital, linked to a major international research institute. It is a provider of mental health and substance misuse services for south London and specialist services for people from across the U.K.
Partners
The Royal Marsden Hospital was the first hospital in the world dedicated to cancer treatment and research into the causes of cancer. Today the hospital with its academic partner, The Institute of Cancer Research, forms the largest comprehensive cancer centre in Europe with over 40,000 patients from the UK and abroad seen each year.
As a company with a firm foundation in science, GlaxoSmithKline (GSK) has a flair for research and a track record of turning that research into marketable drugs. GSK produce medicines that treat six major disease areas – asthma, virus control, infections, mental health, diabetes and digestive conditions. In addition, they are a leader in the important area of vaccines and are developing new treatments for cancer.
Pfizer is a leading pharmaceutical company operating in 180 countries worldwide. Pfizer markets a wide a range of medicines. They are used to treat diseases and conditions in many diverse fields, such as heart disorders, cancer, hypertension, high cholesterol and sexual health.
GE Healthcare provides medical technologies and services that are shaping a new age of patient care. GE Healthcare’s broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. GE Healthcare’s expertise in medical imaging, information technology, medical diagnostics, patient monitoring systems, performance improvement, drug discovery and biopharmaceutical manufacturing is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease.
